Cynosure Inc
- 52 clinical trials
- FDA-cleared or approved devices
- Research grants: $1.4 million
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Syntr Health Technologies, INC
- Raised $795,000 (2022)
- 3 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $6.1 million
TELA Bio, Inc.
Nasdaq: TELA
- Raised $11 million (2019)
- 5 clinical trials, 4 active
- FDA-cleared or approved devices
- Founded 2012
Opko Health, Inc.
Nasdaq: OPK
- Raised $175 million (2013)
- 50 clinical trials, 2 active
- FDA-cleared or approved devices
Macrogenics Inc
Nasdaq: MGNX
- Raised $12 million (2011)
- 43 clinical trials, 5 active
- Research grants: $2.6 million
Sight Sciences, Inc.
Nasdaq: SGHT
- Raised $23 million (2020)
- 17 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2010
Neurolutions Inc
- Raised $27 million (2025)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $3.9 million
Potrero Medical, Inc.
- Raised $6.5 million (2026)
- 7 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $5.8 million
Emergent BioSolutions Inc.
NYSE: EBS
- Raised $48 million (2018)
- 61 clinical trials, 7 active
- 2 FDA-registered drug sites
Vistagen Therapeutics, Inc.
Nasdaq: VTGN
- Raised $2.8 million (2020)
- 11 clinical trials, 3 active
- Research grants: $7.2 million
Guardant Health, Inc.
Nasdaq: GH
- Raised $320 million (2017)
- 10 clinical trials, 6 active
- FDA-cleared or approved devices
- Founded 2011
Tvardi Therapeutics, Inc.
Nasdaq: TVRD
- Raised $72 million (2021)
- 28 clinical trials, 1 active
- Research grants: $1.3 million
- Founded 2017
BioAtla, Inc.
Nasdaq: BCAB
- Raised $5.8 million (2015)
- 6 clinical trials, 2 active
- Research grants: $440,536
Quadrant Biosciences Inc
- Raised $3.5 million (2023)
- 1 clinical trial
- Research grants: $5.6 million
- Founded 2015
Rocket Pharmaceuticals, Inc.
Nasdaq: RCKT
- Raised $24 million (2011)
- 26 clinical trials, 10 active
- Research grants: $38 million
Aradigm Corp
- Raised $23 million (2016)
- 4 clinical trials
- Research grants: $3.6 million
Raydiant Oximetry, Inc.
- Raised $4.3 million (2024)
- 7 clinical trials, 1 active
- 1 FDA-registered device site
- Research grants: $4.3 million
Ionis Pharmaceuticals Inc
Nasdaq: IONS
- Raised $201 million (2012)
- 149 clinical trials, 20 active
- 1 FDA-registered drug site
MediWound Ltd.
Nasdaq: MDWD
- Raised $17 million (2022)
- 15 clinical trials, 4 active
- 1 FDA-registered drug site
Neurocrine Biosciences Inc
Nasdaq: NBIX
- 86 clinical trials, 17 active
- 1 FDA-registered drug site
- Research grants: $10 million
Supernus Pharmaceuticals, Inc.
Nasdaq: SUPN
- Raised $30 million (2012)
- 67 clinical trials, 8 active
- 1 FDA-registered drug site
Inspire Medical Systems, Inc.
NYSE: INSP
- Raised $13 million (2016)
- 13 clinical trials, 5 active
- FDA-cleared or approved devices
Biodexa Pharmaceuticals Plc
Nasdaq: BDRX
- Raised $5 million (2024)
- 4 clinical trials, 2 active
- Founded 2014
CareDx, Inc.
Nasdaq: CDNA
- Raised $22 million (2016)
- 15 clinical trials, 6 active
- FDA-cleared or approved devices
CorMedix Inc.
Nasdaq: CRMD
- Raised $850,000 (2012)
- 6 clinical trials, 2 active
- Research grants: $562,988
- Founded 2006
Embody, Inc.
- Raised $10 million (2022)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $447,814
Miromatrix Medical Inc.
- Raised $16 million (2018)
- 6 clinical trials
- Research grants: $4 million
- Founded 2009
Femasys Inc
Nasdaq: FEMY
- Raised $8 million (2025)
- 6 clinical trials, 2 active
- FDA-cleared or approved devices
Pharmajet, Inc.
- Raised $15 million (2021)
- 6 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $1.7 million
Myomo, Inc.
NYSE: MYO
- Raised $200,000 (2016)
- 5 clinical trials
- 1 FDA-registered device site
- Research grants: $144,645
ViaCyte Inc.
- Raised $54 million (2021)
- 7 clinical trials
- Research grants: $2.7 million
Gilead Sciences, Inc.
Nasdaq: GILD
- 723 clinical trials, 72 active
- 2 FDA-registered drug sites
- Research grants: $1.2 million
Nuwellis, Inc.
Nasdaq: NUWE
- Raised $3.8 million (2024)
- 9 clinical trials
- FDA-cleared or approved devices
Boston Scientific Corp
NYSE: BSX
- 547 clinical trials, 71 active
- FDA-cleared or approved devices
Catalent
On BioBridgeX
- Raised $650 million (2019)
- 4 clinical trials
Kyntra Bio, Inc.
Nasdaq: KYNB
- Raised $20 million (2014)
- 60 clinical trials, 2 active
- Research grants: $1.2 million
Krystal Biotech, Inc.
Nasdaq: KRYS
- Raised $11 million (2017)
- 18 clinical trials, 11 active
- 1 FDA-registered drug site
- Founded 2017
Annovis Bio, Inc.
NYSE: ANVS
- Raised $1.1 million (2023)
- 8 clinical trials, 3 active
- Research grants: $913,507
- Founded 2008
Aptinyx Inc.
- Raised $70 million (2017)
- 8 clinical trials, 1 active
- Research grants: $5.3 million
- Founded 2015
Beta Bionics, Inc.
Nasdaq: BBNX
- Raised $99 million (2023)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2015
Huxley Medical, Inc.
- Raised $3 million (2026)
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $512,414
NeuroTrack Technologies, Inc.
- Raised $21 million (2019)
- 1 clinical trial
- 1 FDA-registered device site
- Research grants: $6.8 million
Bausch & Lomb Inc
- 231 clinical trials, 11 active
- FDA-cleared or approved devices
- 3 FDA-registered drug sites
Posit Science Corp
- Raised $955,360 (2011)
- 36 clinical trials, 2 active
- 1 FDA-registered device site
- Research grants: $27 million
Akouos, Inc.
- Raised $105 million (2020)
- 5 clinical trials, 5 active
- Research grants: $447,136
- Founded 2016
Avidity Biosciences, Inc.
- Raised $400 million (2024)
- 11 clinical trials, 5 active
- Research grants: $200,000
- Founded 2019
Inhibrx, Inc.
- Raised $200 million (2023)
- Research grants: $2.9 million
- Founded 2017
Lucid Diagnostics Inc.
Nasdaq: LUCD
- Raised $22 million (2024)
- 5 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2018
Abiomed Inc
- 33 clinical trials, 12 active
- FDA-cleared or approved devices
- Research grants: $17 million
Immunome Inc.
Nasdaq: IMNM
- Raised $27 million (2021)
- 10 clinical trials, 5 active
- Research grants: $270,025
- Founded 2006
Published company profiles only; counts update daily. Data licences